Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.79 USD | -2.40% |
|
+7.31% | -23.56% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.56% | 2.12B | |
+19.78% | 126B | |
+24.76% | 118B | |
+24.28% | 27.87B | |
-16.97% | 20.95B | |
-14.83% | 16.92B | |
-13.73% | 16.18B | |
+10.40% | 14.84B | |
-47.10% | 14.79B | |
+53.46% | 14.08B |
- Stock Market
- Equities
- RCKT Stock
- News Rocket Pharmaceuticals, Inc.
- Rocket Pharmaceuticals Names Jonathan Schwartz Chief Gene Therapy Officer